Início › Câncer de Próstata › Carolina do Sul
Ensaios clínicos de Câncer de Próstata em Carolina do Sul
42 estudos para Câncer de Próstata estão buscando participantes em locais em Carolina do Sul.
Cidades em Carolina do Sul
- Myrtle Beach23 estudos
- Charleston15 estudos
- Greenville7 estudos
- Greer5 estudos
- Spartanburg5 estudos
- Florence3 estudos
Texto oficial do estudo (Inglês)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- Self Regional Healthcare, Greenwood
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 2 de out. de 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- e mais 12
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Gibbs Cancer Center-Gaffney, Gaffney
- Gibbs Cancer Center-Pelham, Greer
- Spartanburg Medical Center, Spartanburg
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Medical University of South Carolina, Charleston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoEstudo observacional
Idades de 40 a 75 · Homens · Atualizado em 28 de set. de 2026 · NCT07543757Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Myrtle Beach
RecrutandoFase 1/2
Idades de 18 a 130 · Homens · Atualizado em 25 de set. de 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 1/2
Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT06800313Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Carolinas, Myrtle Beach
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07719361Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 2/3
Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 22 de set. de 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- MUSC Hollings Cancer Center, Charleston
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 3
Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Myrtle Beach
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 18 de set. de 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT05011383A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- START Carolinas, Myrtle Beach
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 15 de set. de 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Lowcountry Urology Clinics, North Charleston
Recrutando
Idades 18 e acima · Homens · Atualizado em 14 de set. de 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 11 de set. de 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- McLeod Regional Medical Center, Florence
- Gibbs Cancer Center-Gaffney, Gaffney
- Self Regional Healthcare, Greenwood
- e mais 3
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Medical University of South Carolina - Hollings Cancer Center, Charleston
- Prisma Health Cancer Institute, Greenville
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 3 de set. de 2026 · NCT07545811A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 3 de set. de 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Myrtle Beach
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 26 de ago. de 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 25 de ago. de 2026 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Medical University of South Carolina, Charleston
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 17 de ago. de 2026 · NCT06842498Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Medical University of South Carolina, Charleston
RecrutandoFase 1
Idades de 18 a 100 · Homens · Atualizado em 13 de ago. de 2026 · NCT05519449Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 31 de jul. de 2026 · NCT06613100PSMA PET Combined With MRI for the Detection of PCa
- Atlantic Urology Specialists, Myrtle Beach
RecrutandoFase 3Voluntários saudáveis bem-vindos
Idades 18 e acima · Homens · Atualizado em 23 de jul. de 2026 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Medical University of South Carolina, Charleston
- Levine Cancer Institute-Rock Hill, Rock Hill
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 9 de jul. de 2026 · NCT07103018Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 2 de jul. de 2026 · NCT07140900International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Ralph H. Johnson VA Medical Center, Charleston
RecrutandoEstudo observacional
Idades 21 e acima · Homens · Atualizado em 22 de mai. de 2026 · NCT03151629T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Hollings Cancer Center at Medical University of South Carolina, Charleston
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 4 de mar. de 2026 · NCT05586360Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
- Medical University of South Carolina Hollings Cancer Center, Charleston
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 5 de fev. de 2026 · NCT07325721A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 4 de fev. de 2026 · NCT04729114cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 40 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT05366881Vitamin D for Prostate Endocrine Therapy
- Gibbs Cancer Center-Gaffney, Gaffney
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- e mais 3
RecrutandoFase 3
Idades 50 e acima · Homens · Atualizado em 15 de jan. de 2026 · NCT05838716A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 123, Charleston
- Research Site 108, Greenville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de nov. de 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.